Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 677

1.

Opioid antagonists for alcohol dependence.

Srisurapanont M, Jarusuraisin N.

Cochrane Database Syst Rev. 2002;(2):CD001867. Review. Update in: Cochrane Database Syst Rev. 2005;(1):CD001867.

PMID:
12076425
2.

Opioid antagonists for alcohol dependence.

Srisurapanont M, Jarusuraisin N.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD001867. Review. Update in: Cochrane Database Syst Rev. 2010;(12):CD001867.

PMID:
15674887
3.

Opioid antagonists for alcohol dependence.

Srisurapanont M, Jarusuraisin N.

Cochrane Database Syst Rev. 2000;(3):CD001867. Review. Update in: Cochrane Database Syst Rev. 2002;(2):CD001867.

PMID:
10908513
4.

Opioid antagonists for alcohol dependence.

Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD001867. doi: 10.1002/14651858.CD001867.pub2. Review.

PMID:
21154349
5.

Sertindole for schizophrenia.

Lewis R, Bagnall AM, Leitner M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD001715. Review.

PMID:
16034864
6.

Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.

Marshall M, Crowther R, Almaraz-Serrano A, Creed F, Sledge W, Kluiter H, Roberts C, Hill E, Wiersma D, Bond GR, Huxley P, Tyrer P.

Health Technol Assess. 2001;5(21):1-75. Review.

7.

Quetiapine for schizophrenia.

Srisurapanont M, Maneeton B, Maneeton N.

Cochrane Database Syst Rev. 2004;(2):CD000967. Review.

PMID:
15106155
8.

Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.

Adi Y, Juarez-Garcia A, Wang D, Jowett S, Frew E, Day E, Bayliss S, Roberts T, Burls A.

Health Technol Assess. 2007 Feb;11(6):iii-iv, 1-85. Review.

9.

Oral naltrexone maintenance treatment for opioid dependence.

Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001333. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD001333.

PMID:
16437431
10.

Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses.

Leone MA, Vigna-Taglianti F, Avanzi G, Brambilla R, Faggiano F.

Cochrane Database Syst Rev. 2010 Feb 17;(2):CD006266. doi: 10.1002/14651858.CD006266.pub2. Review.

PMID:
20166080
11.

Thioridazine for schizophrenia.

Sultana A, Reilly J, Fenton M.

Cochrane Database Syst Rev. 2000;(3):CD001944. Review. Update in: Cochrane Database Syst Rev. 2007;(3):CD001944.

PMID:
10908517
12.

Sustained-release naltrexone for opioid dependence.

Lobmaier P, Kornør H, Kunøe N, Bjørndal A.

Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006140. doi: 10.1002/14651858.CD006140.pub2. Review.

PMID:
18425938
13.

Treatment for amphetamine dependence and abuse.

Srisurapanont M, Jarusuraisin N, Kittirattanapaiboon P.

Cochrane Database Syst Rev. 2001;(4):CD003022. Review. Update in: Cochrane Database Syst Rev. 2014;4:CD003022.

PMID:
11687171
14.

Chlorpromazine versus placebo for schizophrenia.

Thornley B, Rathbone J, Adams CE, Awad G.

Cochrane Database Syst Rev. 2003;(2):CD000284. Review. Update in: Cochrane Database Syst Rev. 2007;(2):CD000284.

PMID:
12804394
15.

Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials.

Palpacuer C, Laviolle B, Boussageon R, Reymann JM, Bellissant E, Naudet F.

PLoS Med. 2015 Dec 22;12(12):e1001924. doi: 10.1371/journal.pmed.1001924. Review.

16.

Psychological and/or educational interventions for the prevention of depression in children and adolescents.

Merry S, McDowell H, Hetrick S, Bir J, Muller N.

Cochrane Database Syst Rev. 2004;(1):CD003380. Review. Update in: Cochrane Database Syst Rev. 2011;(12):CD003380.

PMID:
14974014
17.

Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.

MacLeod A, Daly C, Khan I, Vale L, Campbell M, Wallace S, Cody J, Donaldson C, Grant A.

Cochrane Database Syst Rev. 2001;(3):CD003234. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD003234.

PMID:
11687058
18.

Oral naltrexone maintenance treatment for opioid dependence.

Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A.

Cochrane Database Syst Rev. 2011 Apr 13;(4):CD001333. doi: 10.1002/14651858.CD001333.pub4. Review.

PMID:
21491383
19.

Disulfiram for the treatment of cocaine dependence.

Pani PP, Trogu E, Vacca R, Amato L, Vecchi S, Davoli M.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007024. doi: 10.1002/14651858.CD007024.pub2. Review.

PMID:
20091613
20.

Depot bromperidol decanoate for schizophrenia.

Wong D, Adams CE, David A, Quraishi SN.

Cochrane Database Syst Rev. 2004;(3):CD001719. Review. Update in: Cochrane Database Syst Rev. 2011;(9):CD001719.

PMID:
15266450

Supplemental Content

Support Center